Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Aavas Financiers - Q4FY21 Result Update - ICICI Securities

Posted On: 2021-05-02 02:48:10 (Time Zone: UTC)


Resilience instils confidence; deserves premium

Aavas Financiers' (Aavas) FY21 performance demonstrated resilient and best-in-class portfolio quality as indicated by stage-3 assets at 0.98%, 60bps credit cost, 1+ dpd pool at 6.4%, and zero restructuring. Despite running tight filters in self-employed and LAP segments, disbursements were down only 10% in FY21 while AUM growth was >20%. Investing into franchise (adding branches and employees) during a challenging macro instills our confidence in its ability to sustain 25% AUM growth in FY23E and beyond. Core spreads improved through FY21 and can be maintained. Consistency and resilience in FY21, well-contained stress (with 20bps buffer) and franchise investment, enhances visibility towards 3.6% RoAs and 13-15% RoEs by FY22E/FY23E. Valuation premium can expand further to 6.5x FY23E book with greater confidence emerging. Maintain BUY with a revised target price of Rs2,668 (earlier: Rs2,205). Key risks: 1) stress unfolding higher due to covid resurgence; and 2) rising competition, which can weigh on yields or growth.

- Portfolio quality - resilient and comfortably best-in-class; stage-3 sub-1%: Despite the covid-led disruption, the company ended FY21 with a mere 60bps credit cost (on lagged on-book advances) - we can comfortably say this would be amongst the lowest in entire financial space. Compared to 0.5-0.6% stage-3 assets over past few years (0.46% in FY20), it increased in these challenging times to 0.98% (almost flat QoQ) - yet commendable especially when read along with zero restructuring for FY21 and the high-yield nature of portfolio (>13%). 1+ dpd however settled at higher than the normalised level of 6.37% (after a rise in Q3FY21 to 8.2%). Nevertheless, this seems captured to a large extent in stage-3, into which flows were at the usual trend of 10-15%. Management highlighted that it will bring it down to 5% over a couple of quarters through collection efforts. We remain conservative and build-in stage-3 of 1.2-1.3% for FY22E/FY23E.

- Credit cost at 60bps for FY21; carries 20bps contingency buffer: Credit cost too came in much lower at Rs70mn for Q4FY21 (mere 36bps run-rate) taking cumulative credit cost for FY21 to 60bps (on 1-year lagged on-book AUM) - still lower than our expectations. No additional provision has been made towards covid resurgence, which demonstrates the confidence gained from the first wave. This suggests that the existing contingency buffer of Rs190mn (20bps of AUM) should be good enough to manage incremental stress if any. We are building-in 0.4%/0.4% credit cost for FY22E/FY23E.

- Running tight filters in self-employed segment, yet disbursement growth down <10% in FY21: Disbursement growth picked pace in Q4FY21 - up 17% YoY / 32% QoQ to Rs10.1bn. Even with higher repayment run-rate (reflecting better collections), AUM was up 7% QoQ at Rs94.5bn (21% YoY on a higher base). In FY21, Aavas ran tight filters for self-employed customers and was cautious in the LAP segment. Proportion of self-employed in AUM was down from 65% in FY20 to 60.4% in FY21. In fact, turnaround time amidst covid has increased from 10.6 days in FY20 to 13.1 days for FY21. Yet, disbursements were down by <10% in FY21. Anticipating disbursement growth of >35%, we build-in 22-26% of AUM growth over FY22E/FY23E.

- Further investment into franchise in H2FY21 instils confidence: Company is working consistently into building distribution franchise and increasing people capacity. It added 17 branches during the quarter to take the total tally to 280 branches (seven in Rajasthan, four in Uttar Pradesh, two each in Gujarat and Chhattisgarh, and one each in Madhya Pradesh and Punjab/Haryana. In FY21, it has increased employee base by 22% to 4,336. Consequently, employee expenses and other operating expenses were up 16% and 12% respectively in Q4FY21. Franchise investment is intended to prepare and optimise growth opportunities when normalcy sets in. It will remain conservative in underwriting standards but consistent on disbursement momentum. It has also strengthened leadership in technology as that will be the key driver to make it competitive and bring in efficiency.

- Yields have elements of one-offs; core spreads stable: Calculated yield is lower due to some fair value adjustments in the existing securitised pool (Rs40mn impact) and interest income reversal on stage-3 assets (Rs100mn) on a prudent basis However, reported yields during the quarter were down by only 26bps (lending rate was cut 10bps w.e.f. from 1st Jan'21 and further 15 bps w.e.f. from 1st Apr'21), which was offset by 28bps decline in borrowing cost leading to stable spreads at 5.76%. Company securitised Rs1.6bn during the quarter on which it booked Rs274mn securitisation income. Earnings were further buoyed by fee income (up 53%YoY / 46% QoQ). We expect NIMs to be sustained at 6.8-7.0% for FY22E/FY23E.

Shares of AAVAS Financiers Ltd was last trading in BSE at Rs.2268.25 as compared to the previous close of Rs. 2292.95. The total number of shares traded during the day was 3679 in over 906 trades.

The stock hit an intraday high of Rs. 2301.6 and intraday low of 2200.8. The net turnover during the day was Rs. 8254212.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Maintain BUY on CreditAccess Grameen - Accelerated write-offs dents earnings - HDFC Securities

Sundram Fasteners Q4 Results Review - HDFC Securities

SRF - Specialty Chemicals continues to shine! - HDFC Securities

Realtors welcome RBI latest stance, expect relief initiatives in next announcement

CreditAccess Grameen - Q4FY21 Result Update - ICICI Securities

JM Financial - Exits FY21 with well contained stress pool; sequential AUM uptick encouraging - ICICI Securities

Hero MotoCorp - Margins remain resilient - ICICI Securities

CEAT - Margin pressures likely to intensify - ICICI Securities

SRF Limited - FY22E growth capped on higher plants utilisation - ICICI Securities

I-direct Instinct - Automotive Axles - ICICI Direct

Quant Pick - Axis Bank - ICICI Direct

Gladiator Stocks - Caplin Point Laboratories - ICICI Direct

Q4FY21 Result Update - Coforge Ltd - ICICI Direct

Tata Consumer Products - Q4FY21 First Cut - ICICI Direct

Coforge Ltd - Q4FY21 Result Update - YES Securities

CreditAccess Grameen - Q4FY21 Result Update - YES Securities

Blue Star - Q4 FY21 first cut - Inline performance - YES Securities

Tata Consumer - 4QFY21 results first cut - YES Securities

Tata Consumer 4QFY21 results first cut - YES Securities

Maintain BUY on CDSL - Strong growth momentum - HDFC Securities

Maintain ADD on L&T Infotech - Steady progression - HDFC Securities

Blue Dart Express - Q4FY21 - The bulge continues - ICICI Securities

Tata Steel - FY22E Net Debt/EBITDA at <1x - ICICI Securities

Larsen & Toubro Infotech - Consistency continues! - ICICI Securities

CEAT - Decent quarter; new capex likely to curtail FCF - ICICI Securities

Q4FY21 Result Update - Alembic Pharma - ICICI Direct

Gladiator Stocks - Cadila Healthcare - ICICI Direct

Q4FY21 Result Update - Larsen & Toubro Infotech - ICICI Direct

RBI Action Update - May 2021 - ICICI Direct

Quant Pick - Aurobindo Pharma - ICICI Direct

Q4FY21 Result Update - Greaves Cotton - ICICI Direct

Adani Total Gas Ltd - Q4FY21 Result Update - YES Securities

L&T Infotech - Q4FY21 Result Update - YES Securities

Bluedart Express - Q4 FY21 first cut - Miss on topline; Profitability improves - YES Securities

Views on the announcement by RBI Governor - Ms. Bekxy Kuriakose, Head - Fixed Income, Principal Asset Management

Views from experts on RBI announcement - May 5, 2021

Maintain REDUCE on RBL Bank - Elevated retail slippages continue - HDFC Securities

Resolution 2.0 measure by RBI to provide relief to real estate linked SME stakeholders

Godrej Properties - Robust quarter; positives fairly priced in - HDFC Securities

RBI Relief 2.0 - May 2021 - Acuité Ratings & Research

MDF Industry - Countervailing duty on MDF recommended; imports may get hit structurally - ICICI Securities

Home First Finance Company - Core earnings steady; profitability buoyed by securitisation income - ICICI Securities

RBL Bank - Modest return profile in the interim; transitioning underway - ICICI Securities

Alembic Pharmaceuticals - US continues to be under pressure - ICICI Securities

Q4FY21 Result Update - SBI Life Insurance - ICICI Direct

Q1CY21 Result Update - Varun Beverages - ICICI Direct

RBL Bank: Views from leading research houses on Q4FY21 results

Q4FY21 Result Update - Supreme Industries - ICICI Direct

Q4FY21 Result Update - Tata Chemicals - ICICI Direct

Larsen & Toubro Infotech - Q4FY21 First Cut - ICICI Direct


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020